Treatment for PD often includes two types of prescription medications, Levodopa and dopamine agonists. Levodopa, and other similar drugs, are converted to dopamine within the brain. This is considered the gold standard of PD treatment because of its effectiveness in reducing symptoms. On the other hand, dopamine agonists bind to dopamine receptor sites, allowing the brain to ‘think’ it has the dopamine it needs. Other types of drugs are often prescribed to help Levodopa perform more efficiently within the brain.
Prescription drugs only help reduce the symptoms of PD. There is no widely accepted preventative measure that treats the underlying pathology for PD to date. Every year 60,000 new people are diagnosed with PD and $25 billion is spent to treat PD annually. The pressure for effective preventative measures and curative treatments for PD is rising with each new diagnosis.
Recent research on NAD+ therapy has shown promising therapeutic benefits to many neurodegenerative diseases, including PD.